Numerous medications that target CGRP are in simultaneous development for both acute and prophylactic migraine treatment.Acute Migraine TreatmentUbrogepant Ubrogepant was tested for efficacy … read more

Phase II clinical trials of a series of drugs that target calcitonin gene-related peptide (CGRP) have brought another round of promising results, which were presented at the American Headache Societ … read more